Added sugars may increase blood pressure more than high salt consumption
the ONA take:
Added sugars may increase risk of hypertension and cardiovascular disease more than salt, according to new research. Cardiovascular disease is the number one cause of premature mortality, and hypertension is its most important risk factor.
Current preventive measures for hypertension involve restricting dietary sodium, particularly by avoiding processed foods.
However, researchers from the Department of Preventive Cardiology at Saint Luke’s Mid America Heart Institute in Kansas City, Missouri, note that processed foods also have high levels of refined carbohydrates, namely various sugars and simple starches that increase blood glucose levels through digestion.
The most common sugars are sucrose, or table sugar, and high-fructose corn syrup (HFCS), the most frequently used sweetener in processed foods, in particular fruit drinks and sodas. Consuming one 24-ounce soft drink can cause an average maximum increase in blood pressure of 15/9 mm Hg and heart rate of 9 bpm.
The study findings indicate that even moderate doses of added sugars for short durations may cause harm. Consuming naturally occurring sugars, such as whole fruits, however, is not harmful and may even be beneficial.
Added sugars may increase risk of hypertension and cardiovascular disease more than salt.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Robotic Surgery Provides Good Outcomes and Survival in Oropharyngeal Cancer
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|